HNF1A and hepatocellular carcinoma: In other words, approximately 89.71% (with AFP ≤ 20 ng/ml as the cut-off value) or 84.75% (with AFP ≤ 400 ng/ml as the cut-off value) of HCC cases without elevated AFP levels could be explained by the HNF1A genotypes.